SynthesisInternational journal of clinical oncology2020
Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases.
Synthesis in International journal of clinical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.
- Optimal surgical treatment for paratesticular leiomyosarcoma: retrospective analysis of 217 reported cases.BMC cancer · 2022Pooled it
- Atypical metastasis of paratesticular liposarcoma to the penile crus managed with surgical resection.Urology case reports · 2026Article
- Giant well-differentiated liposarcoma of the spermatic cord: Case report.Urology case reports · 2026Article
- Paratesticular liposarcomas: A rare but crucial diagnosis. Case series and review of literature.Central European journal of urology · 2025Review
- Article
- Recurrent paratesticular liposarcoma: a case report.Annals of medicine and surgery (2012) · 2024Article
- Giant paratesticular liposarcoma: A rare case report and literature review.International journal of surgery case reports · 2024Article
- Well-differentiated liposarcoma of spermatic cord presenting as recurrent inguinal hernia: a case report.AME case reports · 2024Article
- Case Report: Giant paratesticular liposarcoma was resected and refused radical orchiectomy.Frontiers in oncology · 2023Article
- Recurrent paratesticular giant liposarcoma: A case report and literature review.Frontiers in surgery · 2023Article
- Case report: Paratesticular dedifferentiated liposarcoma with poor prognosis.Frontiers in oncology · 2022Article
- Case report: Two cases of primary paratesticular liposarcoma.Frontiers in oncology · 2022Article
- A case report of uncommon paratesticular liposarcoma of spermatic cord presenting as a scrotal mass.Urology case reports · 2020Article
- Primary Paratesticular Leiomyosarcoma: A Case Report and Literature Review.Case reports in urology · 2020Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLiposarcoma is one of the most common subtypes of soft tissue sarcoma. Although the standard treatment for localized liposarcoma is surgical resection with negative margins, a treatment specific to paratesticular liposarcoma has yet to be quantitatively evaluated.
methodsA systematic search of Medline, Web of Science, Embase, and Google was performed to find articles describing localized paratesticular liposarcoma published between 1979 and 2018 in English. The final cohort included 265 patients in 183 articles. The starting point was the time of surgical treatment, and the endpoint was the time of recurrence, including local recurrence, or distant metastasis.
resultsThe median patient age was 62 years and the median tumor size was 9.5 cm. In total, 178 patients underwent high inguinal orchiectomy and 40 underwent simple tumorectomy. Based on the Kaplan-Meier curves, recurrence-free survival rates were significantly higher for those who underwent high inguinal orchiectomy than for those who underwent tumorectomy. Moreover, those with microscopic positive margins had a higher risk of recurrence than those with negative margins, but adjuvant radiation therapy after resection had no statistically significant effect on recurrence-free survival, even in subgroup analysis of patients with positive margins. Regarding the pathological subtypes, dedifferentiated, pleomorphic, and round-cell liposarcoma had a higher risk of recurrence than well-differentiated or myxoid liposarcoma. In the multivariate analysis, high inguinal orchiectomy greatly affected recurrence-free survival. The tumor size and histological subtype were independent risk factors for recurrence.
conclusionComplete resection with high inguinal orchiectomy is the optimal treatment for paratesticular liposarcoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.